Australian Amendment no. 234, 235 and 236. These amendments are to:
• Permit the use of 2-methyloxolane as an extraction solvent processing aid in the processing and manufacture of infant formula products, foods for infants, formulated supplementary food for young children and all other foods.
• Permit the sale and use of food derived from a new food produced using gene technology: potato line BG25.
• Permit the use of a protein engineered glucoamylase (EC 3.2.1.3) from a genetically modified strain of Aspergillus niger containing a gene from Gloeophyllum sepiarium.
• Permit the use of Vitamin K2 (menaquinone-7) as a permitted form of vitamin K in food for special medical purposes.
• Permit the use of an immobilised fructosyltransferase (EC 2.4.1.9) from a non-genetically engineered strain of Aspergillus oryzae as processing aid in the manufacture of short-chain fructooligosaccharides (sc-FOS) from sucrose.
• Permit triacylglycerol lipase (EC 3.1.1.3) from genetically modified Komagataella phaffi to be used as a processing aid in the manufacture of bread and bakery products
• Permit the sale and use of food derived from a new food produced using gene technology: sugar beet line KWS20-1
Adoption of recent amendments to joint food standards under the Australia New Zealand Food Standards Code Notice, Amendment No. 234, 235 and 236
Type
Notice
Subjects
Requirements, Law & Policy, Food standards
Published
Last updated